Author: Asianet Pakistan

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe and the Democratic Republic of Congo, is pleased to provide a corporate update after closing the business combination with Hennessy Capital Investment Corp. […]

SYDNEY, July 31, 2025 (GLOBE NEWSWIRE) — Axi, an industry-leading global broker, has been recognised with five awards* from the World Business Outlook Awards for 2025, marking a significant milestone in its continued growth and commitment to excellence: Best CFD Provider Australia Best Forex Trading Platform Australia Best 24/7 Customer Service Provider Australia Best Forex […]

HERE and EROAD Deepen Collaboration to Transform Trucking in Australia and New Zealand EROAD to launch first-ever vehicle-aware navigation application in Oceania, powered by HERE’s advanced platform and vehicle-specific data. Partnership addresses critical challenges in the freight sector, including safety, productivity and compliance. Australia – HERE Technologies, a global leader in digital mapping and location data, is […]

HERE and EROAD Deepen Collaboration to Transform Trucking in Australia and New Zealand EROAD to launch first-ever vehicle-aware navigation application in Oceania, powered by HERE’s advanced platform and vehicle-specific data. Partnership addresses critical challenges in the freight sector, including safety, productivity and compliance. Australia – HERE Technologies, a global leader in digital mapping and location data, is […]

Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion-dollar global […]

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]